In a high-stakes, 48-hour challenge in the Amazon, Ari Grele deployed his "Bugnet" technology to map biodiversity ...

Greenpeace International has filed a lawsuit against U.S. pipeline company Energy Transfer in a Dutch court, the ...

Rondo Therapeutics, a privately held biopharmaceutical immuno-oncology company pioneering the development of next-generation T cell-engaging bispecific antibodies for the treatment of solid tumors, ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th ...

The Union of B.C. Indian Chiefs said in a statement that the answer to the Northern Gateway pipeline from Alberta to the Pacific "is still no," after Alberta Premier Danielle Smith suggested ...

For more information about our science, pipeline and people ... potential delays in the commencement, enrollment, data readouts and completion of preclinical studies and clinical trials; results ...

"We have previously had two well-established types of magnetism," study author Oliver Amin, a postdoctoral researcher at the University of Nottingham in the U.K., told Live Science ...

At ASH 2024, they presented a poster ... get together key data needed to know whether these gene therapies are worth further pursuit. (Former?) Risk - Extremely early-stage pipeline In my last ...

The threat of a trade war between Canada and the United States has put a long-dead pipeline project back in the political spotlight — with at least one former opponent now voicing support for ...

MOSCOW, Jan 20 (Reuters) - Russian President Vladimir Putin announced plans on Friday to build a gas pipeline to Iran aimed at eventually transporting up to 55 billion cubic metres (bcm ...

“Building on our data presented at ASH in December ... and have an oral presentation update on the hematotoxicity model and poster presentation on the impact of deep molecular remissions ...